Alveoli, airways, blood vessels, and the interstitium each reveal different aspects of pulmonary disease. Examining these compartments alongside inflammatory or neoplastic cells helps connect the location and pattern of tissue change with processes such as infection, injury, fibrosis, emphysema, or tumor development. This compartment-based approach supports more precise disease classification than examining isolated cellular features alone.
Hematoxylin and eosin staining provides the routine structural view used to assess lung sections. It allows examination of tissue organization, alveolar and airway changes, vascular structures, interstitium, and inflammatory or neoplastic cells. When this routine view does not fully clarify tissue composition or disease-related features, specialized stains or immunohistochemistry can provide additional information.
Cellular patterns help link microscopic observations to the mechanisms underlying disease or injury. The distribution and character of inflammatory or neoplastic cells, together with changes in surrounding tissue compartments, can indicate how a process affects the lung. Interpreting these relationships is useful for distinguishing disease categories, assessing progression, and identifying features relevant to treatment decisions.
Preparation begins with tissue fixation, followed by sectioning and staining, typically with hematoxylin and eosin. The resulting sections are examined for changes in alveoli, airways, blood vessels, interstitium, and associated cells. This sequence preserves tissue structure and produces a consistent microscopic view that can be supplemented by specialized stains or immunohistochemistry when needed.
Specialized stains and immunohistochemistry are useful when routine hematoxylin and eosin examination does not fully resolve tissue composition or clinically relevant features. These approaches can clarify particular components or biomarkers within a specimen. In medical evaluation, the added information may support disease classification, improve characterization of lung tumors, and inform treatment planning.
In medicine, microscopic findings contribute to diagnosis and classification across conditions including pneumonia, fibrosis, emphysema, and lung tumors. The same approach can help evaluate disease progression and therapeutic responses by comparing structural and cellular changes in tissue. Quantitative image analysis extends this assessment by measuring tissue features and supporting more systematic interpretation of clinically relevant patterns.